nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—ADRB1—dilated cardiomyopathy	0.506	0.543	CbGaD
Bopindolol—ADRB2—dilated cardiomyopathy	0.426	0.457	CbGaD
Bopindolol—Carvedilol—GJA1—dilated cardiomyopathy	0.00181	0.193	CrCbGaD
Bopindolol—Carvedilol—NPPB—dilated cardiomyopathy	0.00181	0.193	CrCbGaD
Bopindolol—Propafenone—SCN5A—dilated cardiomyopathy	0.00103	0.11	CrCbGaD
Bopindolol—Carteolol—ADRB1—dilated cardiomyopathy	0.00092	0.0979	CrCbGaD
Bopindolol—Bupranolol—ADRB1—dilated cardiomyopathy	0.000782	0.0832	CrCbGaD
Bopindolol—Carteolol—ADRB2—dilated cardiomyopathy	0.000773	0.0823	CrCbGaD
Bopindolol—Bupranolol—ADRB2—dilated cardiomyopathy	0.000658	0.07	CrCbGaD
Bopindolol—Propafenone—ADRB1—dilated cardiomyopathy	0.000411	0.0437	CrCbGaD
Bopindolol—Carvedilol—ADRB1—dilated cardiomyopathy	0.00037	0.0394	CrCbGaD
Bopindolol—Carvedilol—ADRB2—dilated cardiomyopathy	0.000311	0.0331	CrCbGaD
Bopindolol—Propranolol—ADRB1—dilated cardiomyopathy	0.000281	0.0299	CrCbGaD
Bopindolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000274	0.00471	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000271	0.00467	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000262	0.00452	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000249	0.0043	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000249	0.0043	CbGpPWpGaD
Bopindolol—Propranolol—ADRB2—dilated cardiomyopathy	0.000237	0.0252	CrCbGaD
Bopindolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000236	0.00407	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000234	0.00403	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000234	0.00403	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000232	0.004	CbGpPWpGaD
Bopindolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.000227	0.0039	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000225	0.00387	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000224	0.00386	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000217	0.00375	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000217	0.00374	CbGpPWpGaD
Bopindolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000215	0.00371	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000212	0.00366	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000202	0.00348	CbGpPWpGaD
Bopindolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000199	0.00343	CbGpPWpGaD
Bopindolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000196	0.00337	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000195	0.00337	CbGpPWpGaD
Bopindolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000195	0.00336	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000192	0.00331	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00019	0.00327	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00019	0.00327	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000186	0.0032	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000186	0.0032	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000184	0.00317	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000182	0.00314	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000178	0.00307	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000178	0.00307	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000177	0.00304	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000173	0.00298	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000173	0.00298	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000171	0.00295	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000169	0.00291	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000167	0.00288	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000167	0.00288	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000166	0.00285	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000165	0.00285	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000161	0.00277	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000159	0.00275	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000158	0.00273	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000157	0.00271	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000154	0.00265	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000152	0.00262	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000149	0.00257	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000148	0.00255	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000148	0.00255	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000146	0.00252	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000145	0.0025	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000145	0.0025	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000143	0.00246	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000142	0.00244	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000142	0.00244	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000142	0.00244	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000142	0.00244	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000139	0.00239	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000138	0.00237	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000136	0.00234	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000135	0.00233	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000135	0.00232	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000133	0.00229	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000132	0.00227	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000132	0.00227	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00013	0.00225	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00013	0.00224	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000128	0.0022	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000127	0.0022	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000127	0.00219	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000127	0.00218	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000126	0.00217	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000121	0.00208	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000114	0.00196	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000113	0.00194	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000113	0.00194	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000111	0.00192	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00011	0.0019	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00011	0.0019	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000109	0.00188	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000109	0.00188	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000108	0.00186	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000108	0.00186	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000108	0.00186	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000107	0.00185	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000107	0.00185	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000105	0.00181	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000103	0.00178	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000103	0.00178	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000103	0.00177	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000103	0.00177	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000101	0.00173	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0001	0.00173	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	9.98e-05	0.00172	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	9.93e-05	0.00171	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.75e-05	0.00168	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.75e-05	0.00168	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	9.71e-05	0.00167	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.67e-05	0.00167	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	9.64e-05	0.00166	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.06e-05	0.00156	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.78e-05	0.00151	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	8.67e-05	0.00149	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	8.48e-05	0.00146	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	8.29e-05	0.00143	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.26e-05	0.00142	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.23e-05	0.00142	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.01e-05	0.00138	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	8e-05	0.00138	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	8e-05	0.00138	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	7.87e-05	0.00136	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	7.84e-05	0.00135	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.83e-05	0.00135	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	7.66e-05	0.00132	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	7.66e-05	0.00132	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.5e-05	0.00129	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	7.44e-05	0.00128	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	7.27e-05	0.00125	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	7.27e-05	0.00125	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	7.2e-05	0.00124	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.11e-05	0.00123	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.76e-05	0.00116	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	6.54e-05	0.00113	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.49e-05	0.00112	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.37e-05	0.0011	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.37e-05	0.0011	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.23e-05	0.00107	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.23e-05	0.00107	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.15e-05	0.00106	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	6.1e-05	0.00105	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.1e-05	0.00105	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.1e-05	0.00105	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.08e-05	0.00105	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	6.06e-05	0.00104	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	5.97e-05	0.00103	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.92e-05	0.00102	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.84e-05	0.00101	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	5.84e-05	0.00101	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.81e-05	0.001	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.8e-05	0.000999	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.79e-05	0.000997	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.79e-05	0.000997	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.76e-05	0.000993	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.76e-05	0.000993	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5.67e-05	0.000977	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.66e-05	0.000975	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.66e-05	0.000975	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.61e-05	0.000967	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.59e-05	0.000963	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	5.54e-05	0.000954	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	5.54e-05	0.000954	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.52e-05	0.000952	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	5.49e-05	0.000946	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.38e-05	0.000927	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.35e-05	0.000923	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.3e-05	0.000913	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—AGT—dilated cardiomyopathy	5.28e-05	0.000909	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.26e-05	0.000907	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.19e-05	0.000894	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.15e-05	0.000887	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.1e-05	0.000878	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.98e-05	0.000859	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.9e-05	0.000844	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.83e-05	0.000833	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.79e-05	0.000826	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.69e-05	0.000808	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.65e-05	0.000801	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.53e-05	0.000781	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.45e-05	0.000767	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.45e-05	0.000766	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.43e-05	0.000763	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.35e-05	0.00075	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.33e-05	0.000746	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.29e-05	0.00074	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.29e-05	0.00074	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.26e-05	0.000733	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.22e-05	0.000727	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.2e-05	0.000724	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.12e-05	0.000709	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.04e-05	0.000696	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.99e-05	0.000688	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	3.93e-05	0.000678	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.86e-05	0.000666	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.85e-05	0.000663	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.77e-05	0.000649	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.68e-05	0.000635	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.66e-05	0.000631	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.61e-05	0.000622	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.61e-05	0.000622	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.53e-05	0.000608	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.45e-05	0.000595	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.45e-05	0.000594	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.42e-05	0.000589	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.42e-05	0.000589	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.37e-05	0.000581	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.34e-05	0.000576	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.34e-05	0.000576	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.3e-05	0.000569	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.3e-05	0.000568	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.28e-05	0.000565	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.27e-05	0.000563	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.27e-05	0.000563	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RAC1—dilated cardiomyopathy	3.26e-05	0.000562	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.21e-05	0.000552	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.18e-05	0.000548	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.13e-05	0.00054	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.13e-05	0.00054	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.13e-05	0.00054	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AGT—dilated cardiomyopathy	3.12e-05	0.000537	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.11e-05	0.000536	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	3.06e-05	0.000528	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.04e-05	0.000524	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.01e-05	0.000519	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	3e-05	0.000516	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.94e-05	0.000507	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.73e-05	0.00047	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.69e-05	0.000464	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.63e-05	0.000453	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.57e-05	0.000443	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.51e-05	0.000433	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.51e-05	0.000433	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.49e-05	0.00043	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.43e-05	0.000419	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.39e-05	0.000411	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	2.32e-05	0.0004	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.17e-05	0.000374	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.16e-05	0.000373	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.14e-05	0.000369	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.13e-05	0.000366	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.1e-05	0.000361	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.08e-05	0.000358	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.05e-05	0.000353	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.94e-05	0.000334	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.89e-05	0.000326	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.87e-05	0.000322	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.85e-05	0.000319	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.85e-05	0.000319	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.81e-05	0.000312	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.77e-05	0.000305	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.61e-05	0.000278	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.49e-05	0.000257	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.48e-05	0.000256	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.46e-05	0.000251	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.43e-05	0.000246	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.28e-05	0.000221	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.26e-05	0.000216	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.23e-05	0.000212	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.11e-05	0.00019	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.8e-06	0.000152	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	8.61e-06	0.000148	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	8.42e-06	0.000145	CbGpPWpGaD
